Blue dye tested in septic shock: a feasibility study
NCT ID NCT06900140
First seen Mar 05, 2026 · Last updated May 12, 2026 · Updated 12 times
Summary
This pilot study tested whether adding methylene blue to usual care is feasible for adults in the intensive care unit with septic shock. Researchers enrolled 50 patients to check recruitment rates, consent rates, and how well doctors followed the treatment plan. The goal was to see if a larger trial is possible, not to prove the treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lakeridge Health Ajax-Pickering
Ajax, Ontario, Canada
-
Lakeridge Health Oshawa
Oshawa, Ontario, Canada
Conditions
Explore the condition pages connected to this study.